JPRN-jRCT2080223577已完成3 期
Phase III long-term study of KRP-108 -open-label, non-controlled, long-term study of KRP-108 in pediatric bronchial asthma
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 53
研究概览
简要总结
o major clinical safety issues were observed when KRP-108 was administered for 24 weeks in Japanese pediatric bronchial asthma patients, and its efficacy was also confirmed.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 5age old 至 <= 15age old（—）
- 性别
- All
入选标准
- •Known history of bronchial asthma for > 12 weeks.
排除标准
- •Complication of chronic pulmonary disease without bronchial asthma and diseases affecting respiratory function.
- •Complication of hypokalemia.
研究者
相似试验
未知
3 期
KRP-108 comparative studyAsthmaJPRN-jRCT2080221303Kyorin Pharmaceutical Co.,LTD
未知
3 期
ong-term safety study of KRP-AB1102COPDJPRN-jRCT2080221930Kyorin Pharmaceutical Co.,LTD.130
已完成
3 期
A Long-term Safety Study of QVM149 in Japanese Patients With AsthmaAsthmaNCT03100825Novartis Pharmaceuticals96
已完成
3 期
A Long-term Safety Study of QMF149 in Japanese Participants With AsthmaAsthmaNCT03100500Novartis Pharmaceuticals51
已完成
1 期
Phase I study of KRP-AM1977X (Clinical pharmacological study)Japanese healthy adult male subjectsJPRN-jRCT2080225163Kyorin Pharmaceutical Co., Ltd.54